Jean Jacques Bienaime insider trades
Open-market stock purchases and sales by Jean Jacques Bienaime, Unknown at Keros Therapeutics, Inc, from SEC Form 4 filings since May 8, 2012.
Track record: 79% of 19 scored buys are up 5% or more since purchase, averaging +38%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | KROS Keros Therapeutics, Inc | Bought | $10.3K |
| Jul 15, 2026 | KROS Keros Therapeutics, Inc | Bought | $10.6K |
| Jun 15, 2026 | KROS Keros Therapeutics, Inc | Bought | $10.2K |
| Jun 10, 2026 | IMNM Immunome Inc | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| Jun 8, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| Jun 5, 2026 | IMNM Immunome Inc | Sold | $9.7K |
| Jun 5, 2026 | IMNM Immunome Inc | Sold | $194K |
| Jun 5, 2026 | IMNM Immunome Inc | Bought | $19.3K |
| Jun 5, 2026 | IMNM Immunome Inc | Bought | $117K |
| Jun 5, 2026 | IMNM Immunome Inc | Bought | $68.1K |
| Jun 3, 2026 | KROS Keros Therapeutics, Inc | Bought (not open market) | — |
| Jun 3, 2026 | KROS Keros Therapeutics, Inc | Bought (not open market) | — |
| May 29, 2026 | ASND Ascendis Pharma A/S | Bought | $22.4K |
| May 29, 2026 | ASND Ascendis Pharma A/S | Bought | $44.5K |
| May 26, 2026 | ASND Ascendis Pharma A/S | Bought | $47.9K |
| May 26, 2026 | INCY Incyte Corp | Sold (not open market) | $1.3M |
| May 26, 2026 | INCY Incyte Corp | Bought (not open market) | — |
| May 15, 2026 | IMNM Immunome Inc | Bought | $104K |
| May 15, 2026 | KROS Keros Therapeutics, Inc | Bought | $10.6K |
| Apr 15, 2026 | KROS Keros Therapeutics, Inc | Bought | $11.7K |
| Mar 11, 2026 | IMNM Immunome Inc | Bought | $21.6K |
| Mar 10, 2026 | IMNM Immunome Inc | Bought | $22.1K |
| Mar 9, 2026 | KROS Keros Therapeutics, Inc | Bought | $22.4K |
Companies traded
- KROS Keros Therapeutics, Inc: 6 buys, last Aug 17, 2026
- IMNM Immunome Inc: 11 buys, 2 sales, last Jun 10, 2026
- INCY Incyte Corp: 6 buys, 3 sales, last Jun 8, 2026
- ASND Ascendis Pharma A/S: 3 buys, last May 29, 2026
- BMRN Biomarin Pharmaceutical Inc: 294 sales, last May 20, 2024
- VTL Vital Therapies Inc: 6 buys, 2 sales, last Sep 24, 2018
- ITMN Intermune Inc: other filings, last Sep 29, 2014
- PTLA Portola Pharmaceuticals Inc: 1 buy, 2 sales, last May 16, 2014
Get free alerts when Jean Jacques Bienaime files a new trade →